Search results
Buy Low, Hold Long: 2 Crushed Dividend Stocks To Buy For High Yields And Long-Term Gains
Benzinga via Yahoo Finance· 7 days agoSuccessful companies sometimes face events that could affect their stock performance. However,...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 5 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WHTC 1450 Holland· 5 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
NIH launches 2 clinical trials testing HIV drug on women, other minority groups
United Press International via Yahoo News· 15 hours agoThe National Institute of Health says they are seeking to now include underrepresented population...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks· 7 hours agoFree Report) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? The ...
Gilead drug fails to confirm its FDA approval in bladder cancer - Silicon Valley Business Journal
The Business Journals· 5 days agoA drug at the center of a $21 billion acquisition by Gilead Sciences Inc. four years ago failed a...
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers
MedPage Today· 1 day agoAt a median follow-up of 11.3 months, the overall response rate (ORR) among the 30 patients who...
Gilead Sciences Inc London Stock Price Today | NASDAQ 0QYQ Live Ticker - Investing.com
Investing.com· 6 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Oral nucleoside antiviral is progressing toward future pandemic preparedness
Medical Xpress· 2 days agoSeveral researchers at the University of North Carolina at Chapel Hill's Gillings School of Global...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 3 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...